PMC4857343_01
The biomechanical device (a) biomechanical device comprising two individually calibrated elements and a foot-worn platform. The elements are attached to under the hindfoot and forefoot regions of the platform. (b) The biomechanical elements are available in different degrees of convexity and resilience. (c) The specially designed sole of the platform includes two mounting rails and a positioning matrix to enable flexible positioning of each biomechanical element.
10.1177_2050313X13519978-fig1.jpg
PMC4857343_01_10.1177_2050313X13519978-fig1.jpg
fig1-2050313X13519978
Changes in gait velocity following 6 months of AposTherapy.
10.1177_2050313X13519978-fig2.jpg
PMC4857343_01_10.1177_2050313X13519978-fig2.jpg
fig2-2050313X13519978
Compared to baseline, velocity steadily increased by 244% of its original value (Figure 2); SL gradually increased by 66% and 90% in the involved and uninvolved limb, respectively (Figure 3); SLS increased by 43% for the involved limb and decreased by 24% for the uninvolved limb (Figure 4) and BOS decreased by 46% and 32% in the involved and uninvolved limb, respectively (Table 1).
Changes in step length following 6 months of AposTherapy.
10.1177_2050313X13519978-fig3.jpg
PMC4857343_01_10.1177_2050313X13519978-fig3.jpg
fig3-2050313X13519978
Compared to baseline, velocity steadily increased by 244% of its original value (Figure 2); SL gradually increased by 66% and 90% in the involved and uninvolved limb, respectively (Figure 3); SLS increased by 43% for the involved limb and decreased by 24% for the uninvolved limb (Figure 4) and BOS decreased by 46% and 32% in the involved and uninvolved limb, respectively (Table 1).
Changes in single limb support following 6 months of AposTherapy.
10.1177_2050313X13519978-fig4.jpg
PMC4857343_01_10.1177_2050313X13519978-fig4.jpg
fig4-2050313X13519978
Compared to baseline, velocity steadily increased by 244% of its original value (Figure 2); SL gradually increased by 66% and 90% in the involved and uninvolved limb, respectively (Figure 3); SLS increased by 43% for the involved limb and decreased by 24% for the uninvolved limb (Figure 4) and BOS decreased by 46% and 32% in the involved and uninvolved limb, respectively (Table 1).